The Heart-Kidney Health Registry Study
Part of Brain & nervous system, Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This is an observational registry that collects information from people with kidney disease who are seen by the kidney team at Royal London Hospital. It helps researchers study heart and kidney health over time without needing extra tests or visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years or older
- You have a kidney-related condition (any stage)
- You are under the care of the kidney team at Royal London Hospital
- Even if you are a vulnerable adult or cannot give consent, you can still join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a kidney disease registry that collects information from people with end-stage kidney failure who are receiving ongoing kidney replacement treatment. It may help doctors better understand kidney disease over time and improve care planning.
This study is for adults with chronic kidney disease (CKD), including people on dialysis or with a kidney transplant. It aims to better support kidney care by allowing more community access to research.
This study is collecting information from people with chronic kidney disease (CKD) to understand how the disease progresses over time. It does not test any new treatments, so you keep your usual care.
This study looks at how heart and kidney problems affect people with advanced heart failure. It aims to understand how these conditions together impact your health and outcomes.
This study checks how heart and kidney health are related in people with kidney disease, diabetes, high blood pressure, or high cholesterol. It is a single visit with tests to see if certain heart problems are common in these conditions.
This study collects health information from people with chronic kidney disease (CKD) and also from some people without CKD but with kidney risk factors. It helps doctors understand how CKD develops and how it’s managed in everyday life, not to test a new drug.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.